Evidence map›Paper›PMID 41787068›Full record

ArticleLeukemia2026

Correction: Regulation of metabolic adaptation and leukemia progression by MUSASHI2-DEPTOR-KIF11 axis.

Tania Setiawan, Jabir Aliyu Muhammad, Nadya Marcelina Julianto, Lawrence Mario Wirawan, Nayoung Jun, Ita Novita Sari, Vivian G Oehler, Dong-Wook Kim, Hyog Young Kwon

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Leukemia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Tania Setiawan *Department of Integrated Biomedical Science, Soonchunhyang University, Cheonan-si, Republic of Korea.
Jabir Aliyu Muhammad *Department of Integrated Biomedical Science, Soonchunhyang University, Cheonan-si, Republic of Korea.
Nadya Marcelina JuliantoDepartment of Integrated Biomedical Science, Soonchunhyang University, Cheonan-si, Republic of Korea.
Lawrence Mario WirawanDepartment of Integrated Biomedical Science, Soonchunhyang University, Cheonan-si, Republic of Korea.
Nayoung JunDepartment of Integrated Biomedical Science, Soonchunhyang University, Cheonan-si, Republic of Korea.
Ita Novita SariDepartment of Integrated Biomedical Science, Soonchunhyang University, Cheonan-si, Republic of Korea.ORCID http://orcid.org/0000-0001-9475-7992
Vivian G OehlerClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Dong-Wook KimDepartment of Hematology, Hematology Center, Uijeongbu Eulji Medical Center, Eulji University, Uijeongbu, Republic of Korea; Leukemia Omics Research Institute, Eulji University Uijeongbu Campus, Uijeongbu, Republic of Korea.ORCID http://orcid.org/0000-0003-3967-4267
Hyog Young KwonDepartment of Integrated Biomedical Science, Soonchunhyang University, Cheonan-si, Republic of Korea. hykwon@sch.ac.kr.ORCID http://orcid.org/0000-0003-1663-5118

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41787068

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.